Methanogenic archaea Methanobrevibacter smithii and Methanosphaera stadtmanae promote mucosal homeostasis and protect from colitis
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2610622123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Emily E Byrd und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908. Hauptthemen laut MEDLINE: Methanobrevibacter, Colitis, Intestinal Mucosa, Methanobacteriaceae. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
The intestinal microbiota is a critical determinant of mucosal homeostasis, yet the functional contributions of Archaea—which constitute up to 10% of the anaerobic community—remain largely undefined. Here, we provide evidence that the human methanogens Methanobrevibacter smithii (MSm) and Methanosphaera stadtmanae (MSt) promote colonic health. Transcriptomic analysis of germ-free mice reveals that MSm and MSt induce distinct colonic programs important for epithelial integrity. Using gnotobiotic and antibiotic-treated specific-pathogen-free mouse models, we show that MSm and MSt reinforce the epithelial barrier, characterized by increased goblet cell expansion, mucus thickening, and enhanced epithelial regeneration. Furthermore, methanogens expand Foxp3 + regulatory T cell (T reg ) populations without inducing pro-inflammatory T H 17 responses. Notably, MSm and MSt protect against dextran sodium sulfate-induced colitis. While MSt-mediated protection requires adaptive immunity, MSm retains partial efficacy in lymphocyte-deficient mice, revealing nonredundant protective mechanisms. These findings indicate that methanogenic archaea promote mucosal integrity during host association and suggest that methanogens may hold therapeutic potential for inflammatory bowel disease, though translation to human disease remains to be established.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908.
- University of Virginia School of Medicine, Charlottesville, VA 22908.
- Department of Genomic Sciences, University of Virginia School of Medicine, Charlottesville, VA 22908.
- Flow Cytometry Core Facility, University of Virginia School of Medicine, Charlottesville, VA 22908.
ORCID-Profile: Emily E Byrd, Benjamin W Harris, Audrey M Putelo, Michael D Solga, Melissa M Kendall
Förderung
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- NIAID NIH HHS
- NCI NIH HHS
Zitieren
APA
Byrd, E. E., Harris, B. W., Zhang, H., Warren, W. E., Kolli, S. H., Putelo, A. M., McGinty, M. T., Solga, M. D., Rutkowski, M. R., & Kendall, M. M. (2026). Methanogenic archaea Methanobrevibacter smithii and Methanosphaera stadtmanae promote mucosal homeostasis and protect from colitis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2610622123
Vancouver
Byrd EE, Harris BW, Zhang H, Warren WE, Kolli SH, Putelo AM, et al. Methanogenic archaea Methanobrevibacter smithii and Methanosphaera stadtmanae promote mucosal homeostasis and protect from colitis. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2610622123
BibTeX
@article{Byrd2026,
author = {Byrd, Emily E and Harris, Benjamin W and Zhang, Hongpan and Warren, W Elise and Kolli, Sree H and Putelo, Audrey M and McGinty, Mitchell T and Solga, Michael D and Rutkowski, Melanie R and Kendall, Melissa M},
title = {Methanogenic archaea Methanobrevibacter smithii and Methanosphaera stadtmanae promote mucosal homeostasis and protect from colitis},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2610622123}
}
EUVIMED